Tolerability of Neratinib in Older Adults with HER2 Positive or HER2 Mutated Metastatic Breast Cancer

Journal of Clinical Oncology / ASCO

View publication ↗

Previous
Previous

Patient Factors Associated with Changes in Functional Status During Systemic Cancer Therapy in Older Adults: A Systematic Review

Next
Next

Strategies to Improve Participation of Older Adults in Cancer Research